Paolo Giuseppe Pino
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Paolo Giuseppe Pino has a total of 23 co-authors. Here are the top co-authors by number of shared publications:
- Giovanni Minardi
Department of Cardiovascular Science, "S. Camillo-Forlanini" Hospital, Rome, Italy
6 shared publications - Carla Manzara
Cardiodiagnostica non invasiva, Department of Cardiology and Cardiovascular Surgery, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy
5 shared publications - Giovanni Pulignano
Cardiodiagnostica non invasiva, Department of Cardiology and Cardiovascular Surgery, Azienda Ospedaliera San Camillo-Forlanini, Rome, Italy
4 shared publications - Herribert Pavaci
Department of Heart and Great Vessels Attilio Reale, Second Division of Cardiology, "Sapienza", University of Rome, Rome, Italy
4 shared publications - Martina Sordi
Interventional Cardiology Unit, “Santa Maria” University Hospital, 05100 Terni, Italy
4 shared publications - Francesco Musumeci
Department of Cardiovascular Science, "S. Camillo-Forlanini" Hospital, Rome, Italy
3 shared publications
Latest Publications
- 15 October 2017
- Published by Springer Nature
- p. 367-379
Diagnosis of Primary Cardiac Malignancies: Echocardiography
- 15 October 2017
- Published by Springer Nature
- p. 367-379
Diagnosis of Primary Cardiac Malignancies: Echocardiography
- Open Access
- 13 July 2010
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 8 (1) , 26
An isolated anterior mitral leaflet cleft: a case report
The anterior mitral leaflet cleft is an unusual congenital lesion most often encountered in association with other congenital heart defects. The isolated anterior leaflet cleft is quite a rare anomaly and is usually cause of mitral valve regurgitation. The importance of the lesion is that it is often correctable. When feasible, cleft suture and, eventually, annuloplasty are preferable to valve replacement. Echocardiography is the first choice technique in the evaluation of mitral valve disease, providing useful information about valve anatomy and hemodynamic parameters.
- 13 July 2010
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 8 (1) , 26
Open AccessAn isolated anterior mitral leaflet cleft: a case report
The anterior mitral leaflet cleft is an unusual congenital lesion most often encountered in association with other congenital heart defects. The isolated anterior leaflet cleft is quite a rare anomaly and is usually cause of mitral valve regurgitation. The importance of the lesion is that it is often correctable. When feasible, cleft suture and, eventually, annuloplasty are preferable to valve replacement. Echocardiography is the first choice technique in the evaluation of mitral valve disease, providing useful information about valve anatomy and hemodynamic parameters.
- Open Access
- 1 January 2010
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 8 (1) , 1
Preoperative scallop-by-scallop assessment of mitral prolapse using 2D-transthoracic echocardiography
This study was conducted to assess the accuracy of harmonic imaging 2D-transthoracic echocardiography (2D-TTE) segmental analysis compared to surgical findings, in degenerative mitral regurgitation (MR).
- 1 January 2010
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 8 (1) , 1
Open AccessPreoperative scallop-by-scallop assessment of mitral prolapse using 2D-transthoracic echocardiography
This study was conducted to assess the accuracy of harmonic imaging 2D-transthoracic echocardiography (2D-TTE) segmental analysis compared to surgical findings, in degenerative mitral regurgitation (MR).
- Open Access
- 24 November 2009
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 3 (1) , 9296
An unusual case of ST-segment elevation myocardial infarction following a late bare-metal stent fracture in a native coronary artery: a case report
A bare-metal stent fracture as a cause of acute coronary thrombosis and consequently of acute coronary syndrome is a rare clinical event that, to the best of our knowledge, has previously not been reported. A stent fracture is a rare complication arising from percutaneous coronary intervention.
- 24 November 2009
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 3 (1) , 9296
Open AccessAn unusual case of ST-segment elevation myocardial infarction following a late bare-metal stent fracture in a native coronary artery: a case report
A bare-metal stent fracture as a cause of acute coronary thrombosis and consequently of acute coronary syndrome is a rare clinical event that, to the best of our knowledge, has previously not been reported. A stent fracture is a rare complication arising from percutaneous coronary intervention.
- Open Access
- 20 November 2009
- Published by Springer Nature in Cases Journal
- Vol. 2 (1) , 9072
Infective endocarditis on mitral annular calcification: a case report
Mitral annular calcification is a common finding in elderly patients; it is considered a benign cardiac abnormality but it can be a predisposing factor for infective endocarditis. Although described in numerous necropsy studies, endocarditis on mitral annular calcification has rarely been reported during life, and the frequency of sepsis can be underestimated because of difficult diagnosis.
- 20 November 2009
- Published by Springer Nature in Cases Journal
- Vol. 2 (1) , 9072
Open AccessInfective endocarditis on mitral annular calcification: a case report
Mitral annular calcification is a common finding in elderly patients; it is considered a benign cardiac abnormality but it can be a predisposing factor for infective endocarditis. Although described in numerous necropsy studies, endocarditis on mitral annular calcification has rarely been reported during life, and the frequency of sepsis can be underestimated because of difficult diagnosis.
- Open Access
- 12 June 2008
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 2 (1) , 205
Caseous calcification of the mitral annulus with mitral regurgitation and impairment of functional capacity: a case report
Mitral annular calcification is a common echocardiographic finding, especially in the elderly. Caseous calcification of the mitral annulus, however, is a relatively rare variant, having an echocardiographic prevalence of 0.6% in patients with mitral annular calcification. Caseous calcification needs to be differentiated from infected mitral annular calcification, mitral annular abscess and tumours. It is not malignant, and medical therapy with clinical follow-up is the therapeutic option. Surgery should be reserved for co-existent mitral valve dysfunction.
- 12 June 2008
- Published by Springer Nature in Journal of Medical Case Reports
- Vol. 2 (1) , 205
Open AccessCaseous calcification of the mitral annulus with mitral regurgitation and impairment of functional capacity: a case report
Mitral annular calcification is a common echocardiographic finding, especially in the elderly. Caseous calcification of the mitral annulus, however, is a relatively rare variant, having an echocardiographic prevalence of 0.6% in patients with mitral annular calcification. Caseous calcification needs to be differentiated from infected mitral annular calcification, mitral annular abscess and tumours. It is not malignant, and medical therapy with clinical follow-up is the therapeutic option. Surgery should be reserved for co-existent mitral valve dysfunction.
- Open Access
- 21 November 2007
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 5 (1) , 40
Feasibility, safety and tolerability of accelerated dobutamine stress echocardiography
A continuous infusion of a single high dose of dobutamine has been, recently, suggested as a simple and effective protocol of stress echocardiography. The present study assesses the feasibility, safety, and tolerability of an accelerated dobutamine stress protocol performed in patients with suspected or known coronary artery disease. Two hundred sixty five consecutive patients underwent accelerated dobutamine stress echocardiography: the dobutamine was administered at a constant dose of 50 μg/kg/min for up to 10 minutes. The mean weight-adjusted cumulative dose of dobutamine used was 330 ± 105.24 μg/kg. Total duration of dobutamine infusion was 6.6 ± 2.1 min. Heart rate rose from 69.9 ± 12.1 to 123.1 ± 22.1 beats/min at peak with a concomitant change in systolic blood pressure (127.6 ± 18.1 vs. 167.6 ± 45.0 mmHg). Dobutamine administration produced a rapid increase in heart rate (9.4 ± 5.9 beats/min2). The side effects were similar to those described with the standard protocol; the most common were frequent premature ventricular complexes (21.5%), frequent premature atrial complexes (1.5%) and non sustained ventricular tachycardia (1.5%); among non cardiac symptoms the most frequent were nausea (3.4%), headache (1.1%) and symptomatic hypotension (1.1%). No major side effects were observed during the test. Our data demonstrate that a continous infusion of a single high dose of dobutamine is a safe and well tolerated method of performing stress echocardiography in patients with suspected or known coronary artery disease. This new protocol requires the administration of lower cumulative dobutamine dose than standard protocol and results in a significant reduction in test time.
- 21 November 2007
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 5 (1) , 40
Open AccessFeasibility, safety and tolerability of accelerated dobutamine stress echocardiography
A continuous infusion of a single high dose of dobutamine has been, recently, suggested as a simple and effective protocol of stress echocardiography. The present study assesses the feasibility, safety, and tolerability of an accelerated dobutamine stress protocol performed in patients with suspected or known coronary artery disease. Two hundred sixty five consecutive patients underwent accelerated dobutamine stress echocardiography: the dobutamine was administered at a constant dose of 50 μg/kg/min for up to 10 minutes. The mean weight-adjusted cumulative dose of dobutamine used was 330 ± 105.24 μg/kg. Total duration of dobutamine infusion was 6.6 ± 2.1 min. Heart rate rose from 69.9 ± 12.1 to 123.1 ± 22.1 beats/min at peak with a concomitant change in systolic blood pressure (127.6 ± 18.1 vs. 167.6 ± 45.0 mmHg). Dobutamine administration produced a rapid increase in heart rate (9.4 ± 5.9 beats/min2). The side effects were similar to those described with the standard protocol; the most common were frequent premature ventricular complexes (21.5%), frequent premature atrial complexes (1.5%) and non sustained ventricular tachycardia (1.5%); among non cardiac symptoms the most frequent were nausea (3.4%), headache (1.1%) and symptomatic hypotension (1.1%). No major side effects were observed during the test. Our data demonstrate that a continous infusion of a single high dose of dobutamine is a safe and well tolerated method of performing stress echocardiography in patients with suspected or known coronary artery disease. This new protocol requires the administration of lower cumulative dobutamine dose than standard protocol and results in a significant reduction in test time.
- Open Access
- 19 September 2005
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 3 (1) , 30
Eustachian valve endocarditis: a rare localization of right side endocarditis. A case report and review of the literature
Background: Right-sided endocarditis occurs predominantly in intravenous drug users, in patients with pacemaker or central venous lines and in patients with congenital heart disease. The vast majority of cases involve the tricuspid valve. Eustachian valve endocarditis is an uncommon disease with similar signs and symptoms of the tricuspid valve endocarditis. A series of only 16 cases of eustachian valve endocarditis are reported in the literature. Case Presentation: We present a case of a 25-year old woman with intravenous drug abuse who had a staphylococcus aureus tricuspid valve endocarditis associated to eustachian valve endocarditis. Transthoracic echocardiography, as first line examination, showed the vegetations on tricuspid and eustachian valve. Conclusion: Our case describe an unusual location of right side endocarditis in a intravenous drug abuser. In our case, in accord with other cases described in the literature, transthoracic echocardiography disclosed eustachian valve endocarditis. Antimicrobial management is not altered by the recognition of eustachian valve endocarditis. Antibiotic treatment and duration of eustachian endocarditis depends on the isolated organism and is similar to antibiotic therapy used in native valve endocarditis.
- 19 September 2005
- Published by Springer Nature in Cardiovascular Ultrasound
- Vol. 3 (1) , 30
Open AccessEustachian valve endocarditis: a rare localization of right side endocarditis. A case report and review of the literature
Background: Right-sided endocarditis occurs predominantly in intravenous drug users, in patients with pacemaker or central venous lines and in patients with congenital heart disease. The vast majority of cases involve the tricuspid valve. Eustachian valve endocarditis is an uncommon disease with similar signs and symptoms of the tricuspid valve endocarditis. A series of only 16 cases of eustachian valve endocarditis are reported in the literature. Case Presentation: We present a case of a 25-year old woman with intravenous drug abuse who had a staphylococcus aureus tricuspid valve endocarditis associated to eustachian valve endocarditis. Transthoracic echocardiography, as first line examination, showed the vegetations on tricuspid and eustachian valve. Conclusion: Our case describe an unusual location of right side endocarditis in a intravenous drug abuser. In our case, in accord with other cases described in the literature, transthoracic echocardiography disclosed eustachian valve endocarditis. Antimicrobial management is not altered by the recognition of eustachian valve endocarditis. Antibiotic treatment and duration of eustachian endocarditis depends on the isolated organism and is similar to antibiotic therapy used in native valve endocarditis.